郭家耀: 外围回落港股考验28,800支持 健倍苗苗(02161.HK)前景乐观
正荣金融业务部副总裁郭家耀称,美股周三(27日)急挫,企业业绩未如理想,加上疫情对经济带来不明朗因素,投资者纷纷获利回吐,三大指数均录得显着跌幅收市。联储局议息结果公布,维持利率及买债计划不变,主席鲍威尔表示疫情对经济仍构成重大下行风险,暗示息口短期难以调升,但言论未有对市况带来太大帮助。美元表现向好,美国十年期债息回落至1.01厘水平,金价及油价走势向下。港股预托证券普遍下跌,预料大市早段跟随外围大幅低开。
内地股市先跌後回升,沪综指走势反覆靠稳,收市上升0.2%,沪深两市成交额略为缩减。
港股表现回落,主要受外围走势拖累,加上投资者趁高获利回吐,大市在30,000点水平暂遇阻力。美股调整势头显现,港股亦借势出现回吐,考验28,800点支持,上方阻力在30,000点水平。
另由雅各臣(02633.HK)分拆的健倍苗苗(02161.HK)公开招股,计划发售4,468.6万股,招股价为1.2元。公司主要业务为医疗保健品推广及分销,产品遍及大中华、东南亚及其他国家。公司的产品组合包括消费者医疗保健品,包括品牌药及健康保健品;及品牌中药,包括非处方品牌中药及浓缩中药颗粒产品。截至2020年底,公司经营194个品牌,包涵逾1,700款产品,当中46个为第三方品牌,148个为自主品牌。
旗下品牌中药包括保济丸、飞鹰活络油、唐大宗活络油,以及自主品牌海天牌的浓缩中药颗粒产品。公司计划进一步扩张产品组合,特别於医疗保健品方面,对准女性保健及育儿领域的药妆及保健产品,以及家用式诊断产品。公司亦积极发展跨境电子商务,透过多个流行平台扩大业务,以捕捉市场机遇,发展前景乐观。
(笔者为证监会持牌人,没持有上述股份)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.